Oruka Therapeutics, Inc. ORKA Pre-Tax Income (Domestic)
Pre-Tax Income (Domestic) at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic.
The official record: Oruka Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s pre-tax income (domestic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s pre-tax income (domestic)?
- Oruka Therapeutics, Inc. (ORKA) reported pre-tax income (domestic) of -$26.36M in Q4 2025.
- How has Oruka Therapeutics, Inc.'s pre-tax income (domestic) changed year-over-year?
- Oruka Therapeutics, Inc.'s pre-tax income (domestic) increased by 68.5% year-over-year, from -$83.72M to -$26.36M.
- What does pre-tax income (domestic) mean?
- The pre-tax profit or loss generated specifically from the company's domestic operations. This metric isolates the financial performance of the home-country business activities before accounting for income tax provisions. It is essential for evaluating the core operational efficiency of the domestic entity.